Global CAR T-Cell-Based Drug Supply, Demand and Key Producers, 2023-2029
The global CAR T-Cell-Based Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report studies the global CAR T-Cell-Based Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CAR T-Cell-Based Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR T-Cell-Based Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CAR T-Cell-Based Drug total market, 2018-2029, (USD Million)
Global CAR T-Cell-Based Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CAR T-Cell-Based Drug total market, key domestic companies and share, (USD Million)
Global CAR T-Cell-Based Drug revenue by player and market share 2018-2023, (USD Million)
Global CAR T-Cell-Based Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global CAR T-Cell-Based Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CAR T-Cell-Based Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics and Sorrento Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR T-Cell-Based Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CAR T-Cell-Based Drug Market, By Region:
1. How big is the global CAR T-Cell-Based Drug market?
2. What is the demand of the global CAR T-Cell-Based Drug market?
3. What is the year over year growth of the global CAR T-Cell-Based Drug market?
4. What is the total value of the global CAR T-Cell-Based Drug market?
5. Who are the major players in the global CAR T-Cell-Based Drug market?
6. What are the growth factors driving the market demand?
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report studies the global CAR T-Cell-Based Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CAR T-Cell-Based Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR T-Cell-Based Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CAR T-Cell-Based Drug total market, 2018-2029, (USD Million)
Global CAR T-Cell-Based Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CAR T-Cell-Based Drug total market, key domestic companies and share, (USD Million)
Global CAR T-Cell-Based Drug revenue by player and market share 2018-2023, (USD Million)
Global CAR T-Cell-Based Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global CAR T-Cell-Based Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CAR T-Cell-Based Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics and Sorrento Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR T-Cell-Based Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CAR T-Cell-Based Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CD19-targeted
- BCMA-targeted
- Lymphoma
- Multiple Myeloma
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics
- Autolus Therapeutics
- Sorrento Therapeutics
- Mustang Bio
- Bluebird Bio
- Cellectis
- Allogene Therapeutics
- Celyad
1. How big is the global CAR T-Cell-Based Drug market?
2. What is the demand of the global CAR T-Cell-Based Drug market?
3. What is the year over year growth of the global CAR T-Cell-Based Drug market?
4. What is the total value of the global CAR T-Cell-Based Drug market?
5. Who are the major players in the global CAR T-Cell-Based Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CAR T-Cell-Based Drug Introduction
1.2 World CAR T-Cell-Based Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CAR T-Cell-Based Drug Total Market by Region (by Headquarter Location)
1.3.1 World CAR T-Cell-Based Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.3 China CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.4 Europe CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.5 Japan CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.6 South Korea CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.7 ASEAN CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.8 India CAR T-Cell-Based Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR T-Cell-Based Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CAR T-Cell-Based Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.2 World CAR T-Cell-Based Drug Consumption Value by Region
2.2.1 World CAR T-Cell-Based Drug Consumption Value by Region (2018-2023)
2.2.2 World CAR T-Cell-Based Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.4 China CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.5 Europe CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.6 Japan CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.7 South Korea CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.8 ASEAN CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.9 India CAR T-Cell-Based Drug Consumption Value (2018-2029)
3 WORLD CAR T-CELL-BASED DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World CAR T-Cell-Based Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CAR T-Cell-Based Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CAR T-Cell-Based Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for CAR T-Cell-Based Drug in 2022
3.3 CAR T-Cell-Based Drug Company Evaluation Quadrant
3.4 CAR T-Cell-Based Drug Market: Overall Company Footprint Analysis
3.4.1 CAR T-Cell-Based Drug Market: Region Footprint
3.4.2 CAR T-Cell-Based Drug Market: Company Product Type Footprint
3.4.3 CAR T-Cell-Based Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CAR T-Cell-Based Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CAR T-Cell-Based Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CAR T-Cell-Based Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CAR T-Cell-Based Drug Consumption Value Comparison
4.2.1 United States VS China: CAR T-Cell-Based Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CAR T-Cell-Based Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CAR T-Cell-Based Drug Companies and Market Share, 2018-2023
4.3.1 United States Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023)
4.4 China Based Companies CAR T-Cell-Based Drug Revenue and Market Share, 2018-2023
4.4.1 China Based CAR T-Cell-Based Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023)
4.5 Rest of World Based CAR T-Cell-Based Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CAR T-Cell-Based Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19-targeted
5.2.2 BCMA-targeted
5.3 Market Segment by Type
5.3.1 World CAR T-Cell-Based Drug Market Size by Type (2018-2023)
5.3.2 World CAR T-Cell-Based Drug Market Size by Type (2024-2029)
5.3.3 World CAR T-Cell-Based Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CAR T-Cell-Based Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lymphoma
6.2.2 Multiple Myeloma
6.3 Market Segment by Application
6.3.1 World CAR T-Cell-Based Drug Market Size by Application (2018-2023)
6.3.2 World CAR T-Cell-Based Drug Market Size by Application (2024-2029)
6.3.3 World CAR T-Cell-Based Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis CAR T-Cell-Based Drug Product and Services
7.1.4 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences CAR T-Cell-Based Drug Product and Services
7.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Details
7.3.2 Bristol-Myers Squibb Major Business
7.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Services
7.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bristol-Myers Squibb Recent Developments/Updates
7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.4 J & J
7.4.1 J & J Details
7.4.2 J & J Major Business
7.4.3 J & J CAR T-Cell-Based Drug Product and Services
7.4.4 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 J & J Recent Developments/Updates
7.4.6 J & J Competitive Strengths & Weaknesses
7.5 JW Therapeutics
7.5.1 JW Therapeutics Details
7.5.2 JW Therapeutics Major Business
7.5.3 JW Therapeutics CAR T-Cell-Based Drug Product and Services
7.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 JW Therapeutics Recent Developments/Updates
7.5.6 JW Therapeutics Competitive Strengths & Weaknesses
7.6 FOSUNKite
7.6.1 FOSUNKite Details
7.6.2 FOSUNKite Major Business
7.6.3 FOSUNKite CAR T-Cell-Based Drug Product and Services
7.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 FOSUNKite Recent Developments/Updates
7.6.6 FOSUNKite Competitive Strengths & Weaknesses
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Details
7.7.2 CARsgen Therapeutics Major Business
7.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product and Services
7.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 CARsgen Therapeutics Recent Developments/Updates
7.7.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Details
7.8.2 Autolus Therapeutics Major Business
7.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product and Services
7.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Autolus Therapeutics Recent Developments/Updates
7.8.6 Autolus Therapeutics Competitive Strengths & Weaknesses
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Details
7.9.2 Sorrento Therapeutics Major Business
7.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product and Services
7.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sorrento Therapeutics Recent Developments/Updates
7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
7.10 Mustang Bio
7.10.1 Mustang Bio Details
7.10.2 Mustang Bio Major Business
7.10.3 Mustang Bio CAR T-Cell-Based Drug Product and Services
7.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Mustang Bio Recent Developments/Updates
7.10.6 Mustang Bio Competitive Strengths & Weaknesses
7.11 Bluebird Bio
7.11.1 Bluebird Bio Details
7.11.2 Bluebird Bio Major Business
7.11.3 Bluebird Bio CAR T-Cell-Based Drug Product and Services
7.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bluebird Bio Recent Developments/Updates
7.11.6 Bluebird Bio Competitive Strengths & Weaknesses
7.12 Cellectis
7.12.1 Cellectis Details
7.12.2 Cellectis Major Business
7.12.3 Cellectis CAR T-Cell-Based Drug Product and Services
7.12.4 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cellectis Recent Developments/Updates
7.12.6 Cellectis Competitive Strengths & Weaknesses
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Details
7.13.2 Allogene Therapeutics Major Business
7.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product and Services
7.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Allogene Therapeutics Recent Developments/Updates
7.13.6 Allogene Therapeutics Competitive Strengths & Weaknesses
7.14 Celyad
7.14.1 Celyad Details
7.14.2 Celyad Major Business
7.14.3 Celyad CAR T-Cell-Based Drug Product and Services
7.14.4 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Celyad Recent Developments/Updates
7.14.6 Celyad Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CAR T-Cell-Based Drug Industry Chain
8.2 CAR T-Cell-Based Drug Upstream Analysis
8.3 CAR T-Cell-Based Drug Midstream Analysis
8.4 CAR T-Cell-Based Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CAR T-Cell-Based Drug Introduction
1.2 World CAR T-Cell-Based Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CAR T-Cell-Based Drug Total Market by Region (by Headquarter Location)
1.3.1 World CAR T-Cell-Based Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.3 China CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.4 Europe CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.5 Japan CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.6 South Korea CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.7 ASEAN CAR T-Cell-Based Drug Market Size (2018-2029)
1.3.8 India CAR T-Cell-Based Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR T-Cell-Based Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CAR T-Cell-Based Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.2 World CAR T-Cell-Based Drug Consumption Value by Region
2.2.1 World CAR T-Cell-Based Drug Consumption Value by Region (2018-2023)
2.2.2 World CAR T-Cell-Based Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.4 China CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.5 Europe CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.6 Japan CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.7 South Korea CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.8 ASEAN CAR T-Cell-Based Drug Consumption Value (2018-2029)
2.9 India CAR T-Cell-Based Drug Consumption Value (2018-2029)
3 WORLD CAR T-CELL-BASED DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World CAR T-Cell-Based Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CAR T-Cell-Based Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CAR T-Cell-Based Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for CAR T-Cell-Based Drug in 2022
3.3 CAR T-Cell-Based Drug Company Evaluation Quadrant
3.4 CAR T-Cell-Based Drug Market: Overall Company Footprint Analysis
3.4.1 CAR T-Cell-Based Drug Market: Region Footprint
3.4.2 CAR T-Cell-Based Drug Market: Company Product Type Footprint
3.4.3 CAR T-Cell-Based Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CAR T-Cell-Based Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CAR T-Cell-Based Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CAR T-Cell-Based Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CAR T-Cell-Based Drug Consumption Value Comparison
4.2.1 United States VS China: CAR T-Cell-Based Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CAR T-Cell-Based Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CAR T-Cell-Based Drug Companies and Market Share, 2018-2023
4.3.1 United States Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023)
4.4 China Based Companies CAR T-Cell-Based Drug Revenue and Market Share, 2018-2023
4.4.1 China Based CAR T-Cell-Based Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023)
4.5 Rest of World Based CAR T-Cell-Based Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CAR T-Cell-Based Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19-targeted
5.2.2 BCMA-targeted
5.3 Market Segment by Type
5.3.1 World CAR T-Cell-Based Drug Market Size by Type (2018-2023)
5.3.2 World CAR T-Cell-Based Drug Market Size by Type (2024-2029)
5.3.3 World CAR T-Cell-Based Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CAR T-Cell-Based Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lymphoma
6.2.2 Multiple Myeloma
6.3 Market Segment by Application
6.3.1 World CAR T-Cell-Based Drug Market Size by Application (2018-2023)
6.3.2 World CAR T-Cell-Based Drug Market Size by Application (2024-2029)
6.3.3 World CAR T-Cell-Based Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis CAR T-Cell-Based Drug Product and Services
7.1.4 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences CAR T-Cell-Based Drug Product and Services
7.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Details
7.3.2 Bristol-Myers Squibb Major Business
7.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Services
7.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bristol-Myers Squibb Recent Developments/Updates
7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.4 J & J
7.4.1 J & J Details
7.4.2 J & J Major Business
7.4.3 J & J CAR T-Cell-Based Drug Product and Services
7.4.4 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 J & J Recent Developments/Updates
7.4.6 J & J Competitive Strengths & Weaknesses
7.5 JW Therapeutics
7.5.1 JW Therapeutics Details
7.5.2 JW Therapeutics Major Business
7.5.3 JW Therapeutics CAR T-Cell-Based Drug Product and Services
7.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 JW Therapeutics Recent Developments/Updates
7.5.6 JW Therapeutics Competitive Strengths & Weaknesses
7.6 FOSUNKite
7.6.1 FOSUNKite Details
7.6.2 FOSUNKite Major Business
7.6.3 FOSUNKite CAR T-Cell-Based Drug Product and Services
7.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 FOSUNKite Recent Developments/Updates
7.6.6 FOSUNKite Competitive Strengths & Weaknesses
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Details
7.7.2 CARsgen Therapeutics Major Business
7.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product and Services
7.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 CARsgen Therapeutics Recent Developments/Updates
7.7.6 CARsgen Therapeutics Competitive Strengths & Weaknesses
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Details
7.8.2 Autolus Therapeutics Major Business
7.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product and Services
7.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Autolus Therapeutics Recent Developments/Updates
7.8.6 Autolus Therapeutics Competitive Strengths & Weaknesses
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Details
7.9.2 Sorrento Therapeutics Major Business
7.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product and Services
7.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sorrento Therapeutics Recent Developments/Updates
7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
7.10 Mustang Bio
7.10.1 Mustang Bio Details
7.10.2 Mustang Bio Major Business
7.10.3 Mustang Bio CAR T-Cell-Based Drug Product and Services
7.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Mustang Bio Recent Developments/Updates
7.10.6 Mustang Bio Competitive Strengths & Weaknesses
7.11 Bluebird Bio
7.11.1 Bluebird Bio Details
7.11.2 Bluebird Bio Major Business
7.11.3 Bluebird Bio CAR T-Cell-Based Drug Product and Services
7.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bluebird Bio Recent Developments/Updates
7.11.6 Bluebird Bio Competitive Strengths & Weaknesses
7.12 Cellectis
7.12.1 Cellectis Details
7.12.2 Cellectis Major Business
7.12.3 Cellectis CAR T-Cell-Based Drug Product and Services
7.12.4 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cellectis Recent Developments/Updates
7.12.6 Cellectis Competitive Strengths & Weaknesses
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Details
7.13.2 Allogene Therapeutics Major Business
7.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product and Services
7.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Allogene Therapeutics Recent Developments/Updates
7.13.6 Allogene Therapeutics Competitive Strengths & Weaknesses
7.14 Celyad
7.14.1 Celyad Details
7.14.2 Celyad Major Business
7.14.3 Celyad CAR T-Cell-Based Drug Product and Services
7.14.4 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Celyad Recent Developments/Updates
7.14.6 Celyad Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CAR T-Cell-Based Drug Industry Chain
8.2 CAR T-Cell-Based Drug Upstream Analysis
8.3 CAR T-Cell-Based Drug Midstream Analysis
8.4 CAR T-Cell-Based Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CAR T-Cell-Based Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CAR T-Cell-Based Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CAR T-Cell-Based Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CAR T-Cell-Based Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CAR T-Cell-Based Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CAR T-Cell-Based Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CAR T-Cell-Based Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CAR T-Cell-Based Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CAR T-Cell-Based Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CAR T-Cell-Based Drug Players in 2022
Table 12. World CAR T-Cell-Based Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CAR T-Cell-Based Drug Company Evaluation Quadrant
Table 14. Head Office of Key CAR T-Cell-Based Drug Player
Table 15. CAR T-Cell-Based Drug Market: Company Product Type Footprint
Table 16. CAR T-Cell-Based Drug Market: Company Product Application Footprint
Table 17. CAR T-Cell-Based Drug Mergers & Acquisitions Activity
Table 18. United States VS China CAR T-Cell-Based Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CAR T-Cell-Based Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CAR T-Cell-Based Drug Revenue Market Share (2018-2023)
Table 23. China Based CAR T-Cell-Based Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CAR T-Cell-Based Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CAR T-Cell-Based Drug Revenue Market Share (2018-2023)
Table 29. World CAR T-Cell-Based Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CAR T-Cell-Based Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World CAR T-Cell-Based Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World CAR T-Cell-Based Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CAR T-Cell-Based Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World CAR T-Cell-Based Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Novartis Basic Information, Area Served and Competitors
Table 36. Novartis Major Business
Table 37. Novartis CAR T-Cell-Based Drug Product and Services
Table 38. Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Novartis Recent Developments/Updates
Table 40. Novartis Competitive Strengths & Weaknesses
Table 41. Gilead Sciences Basic Information, Area Served and Competitors
Table 42. Gilead Sciences Major Business
Table 43. Gilead Sciences CAR T-Cell-Based Drug Product and Services
Table 44. Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gilead Sciences Recent Developments/Updates
Table 46. Gilead Sciences Competitive Strengths & Weaknesses
Table 47. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 48. Bristol-Myers Squibb Major Business
Table 49. Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Services
Table 50. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bristol-Myers Squibb Recent Developments/Updates
Table 52. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 53. J & J Basic Information, Area Served and Competitors
Table 54. J & J Major Business
Table 55. J & J CAR T-Cell-Based Drug Product and Services
Table 56. J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. J & J Recent Developments/Updates
Table 58. J & J Competitive Strengths & Weaknesses
Table 59. JW Therapeutics Basic Information, Area Served and Competitors
Table 60. JW Therapeutics Major Business
Table 61. JW Therapeutics CAR T-Cell-Based Drug Product and Services
Table 62. JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. JW Therapeutics Recent Developments/Updates
Table 64. JW Therapeutics Competitive Strengths & Weaknesses
Table 65. FOSUNKite Basic Information, Area Served and Competitors
Table 66. FOSUNKite Major Business
Table 67. FOSUNKite CAR T-Cell-Based Drug Product and Services
Table 68. FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. FOSUNKite Recent Developments/Updates
Table 70. FOSUNKite Competitive Strengths & Weaknesses
Table 71. CARsgen Therapeutics Basic Information, Area Served and Competitors
Table 72. CARsgen Therapeutics Major Business
Table 73. CARsgen Therapeutics CAR T-Cell-Based Drug Product and Services
Table 74. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. CARsgen Therapeutics Recent Developments/Updates
Table 76. CARsgen Therapeutics Competitive Strengths & Weaknesses
Table 77. Autolus Therapeutics Basic Information, Area Served and Competitors
Table 78. Autolus Therapeutics Major Business
Table 79. Autolus Therapeutics CAR T-Cell-Based Drug Product and Services
Table 80. Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Autolus Therapeutics Recent Developments/Updates
Table 82. Autolus Therapeutics Competitive Strengths & Weaknesses
Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
Table 84. Sorrento Therapeutics Major Business
Table 85. Sorrento Therapeutics CAR T-Cell-Based Drug Product and Services
Table 86. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sorrento Therapeutics Recent Developments/Updates
Table 88. Sorrento Therapeutics Competitive Strengths & Weaknesses
Table 89. Mustang Bio Basic Information, Area Served and Competitors
Table 90. Mustang Bio Major Business
Table 91. Mustang Bio CAR T-Cell-Based Drug Product and Services
Table 92. Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Mustang Bio Recent Developments/Updates
Table 94. Mustang Bio Competitive Strengths & Weaknesses
Table 95. Bluebird Bio Basic Information, Area Served and Competitors
Table 96. Bluebird Bio Major Business
Table 97. Bluebird Bio CAR T-Cell-Based Drug Product and Services
Table 98. Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bluebird Bio Recent Developments/Updates
Table 100. Bluebird Bio Competitive Strengths & Weaknesses
Table 101. Cellectis Basic Information, Area Served and Competitors
Table 102. Cellectis Major Business
Table 103. Cellectis CAR T-Cell-Based Drug Product and Services
Table 104. Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cellectis Recent Developments/Updates
Table 106. Cellectis Competitive Strengths & Weaknesses
Table 107. Allogene Therapeutics Basic Information, Area Served and Competitors
Table 108. Allogene Therapeutics Major Business
Table 109. Allogene Therapeutics CAR T-Cell-Based Drug Product and Services
Table 110. Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Allogene Therapeutics Recent Developments/Updates
Table 112. Celyad Basic Information, Area Served and Competitors
Table 113. Celyad Major Business
Table 114. Celyad CAR T-Cell-Based Drug Product and Services
Table 115. Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of CAR T-Cell-Based Drug Upstream (Raw Materials)
Table 117. CAR T-Cell-Based Drug Typical Customers
Table 1. World CAR T-Cell-Based Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CAR T-Cell-Based Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CAR T-Cell-Based Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CAR T-Cell-Based Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CAR T-Cell-Based Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CAR T-Cell-Based Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CAR T-Cell-Based Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CAR T-Cell-Based Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CAR T-Cell-Based Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CAR T-Cell-Based Drug Players in 2022
Table 12. World CAR T-Cell-Based Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CAR T-Cell-Based Drug Company Evaluation Quadrant
Table 14. Head Office of Key CAR T-Cell-Based Drug Player
Table 15. CAR T-Cell-Based Drug Market: Company Product Type Footprint
Table 16. CAR T-Cell-Based Drug Market: Company Product Application Footprint
Table 17. CAR T-Cell-Based Drug Mergers & Acquisitions Activity
Table 18. United States VS China CAR T-Cell-Based Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CAR T-Cell-Based Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CAR T-Cell-Based Drug Revenue Market Share (2018-2023)
Table 23. China Based CAR T-Cell-Based Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CAR T-Cell-Based Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based CAR T-Cell-Based Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CAR T-Cell-Based Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CAR T-Cell-Based Drug Revenue Market Share (2018-2023)
Table 29. World CAR T-Cell-Based Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CAR T-Cell-Based Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World CAR T-Cell-Based Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World CAR T-Cell-Based Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CAR T-Cell-Based Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World CAR T-Cell-Based Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Novartis Basic Information, Area Served and Competitors
Table 36. Novartis Major Business
Table 37. Novartis CAR T-Cell-Based Drug Product and Services
Table 38. Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Novartis Recent Developments/Updates
Table 40. Novartis Competitive Strengths & Weaknesses
Table 41. Gilead Sciences Basic Information, Area Served and Competitors
Table 42. Gilead Sciences Major Business
Table 43. Gilead Sciences CAR T-Cell-Based Drug Product and Services
Table 44. Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gilead Sciences Recent Developments/Updates
Table 46. Gilead Sciences Competitive Strengths & Weaknesses
Table 47. Bristol-Myers Squibb Basic Information, Area Served and Competitors
Table 48. Bristol-Myers Squibb Major Business
Table 49. Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Services
Table 50. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bristol-Myers Squibb Recent Developments/Updates
Table 52. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 53. J & J Basic Information, Area Served and Competitors
Table 54. J & J Major Business
Table 55. J & J CAR T-Cell-Based Drug Product and Services
Table 56. J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. J & J Recent Developments/Updates
Table 58. J & J Competitive Strengths & Weaknesses
Table 59. JW Therapeutics Basic Information, Area Served and Competitors
Table 60. JW Therapeutics Major Business
Table 61. JW Therapeutics CAR T-Cell-Based Drug Product and Services
Table 62. JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. JW Therapeutics Recent Developments/Updates
Table 64. JW Therapeutics Competitive Strengths & Weaknesses
Table 65. FOSUNKite Basic Information, Area Served and Competitors
Table 66. FOSUNKite Major Business
Table 67. FOSUNKite CAR T-Cell-Based Drug Product and Services
Table 68. FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. FOSUNKite Recent Developments/Updates
Table 70. FOSUNKite Competitive Strengths & Weaknesses
Table 71. CARsgen Therapeutics Basic Information, Area Served and Competitors
Table 72. CARsgen Therapeutics Major Business
Table 73. CARsgen Therapeutics CAR T-Cell-Based Drug Product and Services
Table 74. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. CARsgen Therapeutics Recent Developments/Updates
Table 76. CARsgen Therapeutics Competitive Strengths & Weaknesses
Table 77. Autolus Therapeutics Basic Information, Area Served and Competitors
Table 78. Autolus Therapeutics Major Business
Table 79. Autolus Therapeutics CAR T-Cell-Based Drug Product and Services
Table 80. Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Autolus Therapeutics Recent Developments/Updates
Table 82. Autolus Therapeutics Competitive Strengths & Weaknesses
Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
Table 84. Sorrento Therapeutics Major Business
Table 85. Sorrento Therapeutics CAR T-Cell-Based Drug Product and Services
Table 86. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sorrento Therapeutics Recent Developments/Updates
Table 88. Sorrento Therapeutics Competitive Strengths & Weaknesses
Table 89. Mustang Bio Basic Information, Area Served and Competitors
Table 90. Mustang Bio Major Business
Table 91. Mustang Bio CAR T-Cell-Based Drug Product and Services
Table 92. Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Mustang Bio Recent Developments/Updates
Table 94. Mustang Bio Competitive Strengths & Weaknesses
Table 95. Bluebird Bio Basic Information, Area Served and Competitors
Table 96. Bluebird Bio Major Business
Table 97. Bluebird Bio CAR T-Cell-Based Drug Product and Services
Table 98. Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bluebird Bio Recent Developments/Updates
Table 100. Bluebird Bio Competitive Strengths & Weaknesses
Table 101. Cellectis Basic Information, Area Served and Competitors
Table 102. Cellectis Major Business
Table 103. Cellectis CAR T-Cell-Based Drug Product and Services
Table 104. Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cellectis Recent Developments/Updates
Table 106. Cellectis Competitive Strengths & Weaknesses
Table 107. Allogene Therapeutics Basic Information, Area Served and Competitors
Table 108. Allogene Therapeutics Major Business
Table 109. Allogene Therapeutics CAR T-Cell-Based Drug Product and Services
Table 110. Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Allogene Therapeutics Recent Developments/Updates
Table 112. Celyad Basic Information, Area Served and Competitors
Table 113. Celyad Major Business
Table 114. Celyad CAR T-Cell-Based Drug Product and Services
Table 115. Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of CAR T-Cell-Based Drug Upstream (Raw Materials)
Table 117. CAR T-Cell-Based Drug Typical Customers
LIST OF FIGURES
Figure 1. CAR T-Cell-Based Drug Picture
Figure 2. World CAR T-Cell-Based Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CAR T-Cell-Based Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World CAR T-Cell-Based Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CAR T-Cell-Based Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 13. CAR T-Cell-Based Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World CAR T-Cell-Based Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CAR T-Cell-Based Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR T-Cell-Based Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR T-Cell-Based Drug Markets in 2022
Figure 27. United States VS China: CAR T-Cell-Based Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CAR T-Cell-Based Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CAR T-Cell-Based Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CAR T-Cell-Based Drug Market Size Market Share by Type in 2022
Figure 31. CD19-targeted
Figure 32. BCMA-targeted
Figure 33. World CAR T-Cell-Based Drug Market Size Market Share by Type (2018-2029)
Figure 34. World CAR T-Cell-Based Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CAR T-Cell-Based Drug Market Size Market Share by Application in 2022
Figure 36. Lymphoma
Figure 37. Multiple Myeloma
Figure 38. CAR T-Cell-Based Drug Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. CAR T-Cell-Based Drug Picture
Figure 2. World CAR T-Cell-Based Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CAR T-Cell-Based Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World CAR T-Cell-Based Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CAR T-Cell-Based Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CAR T-Cell-Based Drug Revenue (2018-2029) & (USD Million)
Figure 13. CAR T-Cell-Based Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World CAR T-Cell-Based Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CAR T-Cell-Based Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR T-Cell-Based Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR T-Cell-Based Drug Markets in 2022
Figure 27. United States VS China: CAR T-Cell-Based Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CAR T-Cell-Based Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CAR T-Cell-Based Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CAR T-Cell-Based Drug Market Size Market Share by Type in 2022
Figure 31. CD19-targeted
Figure 32. BCMA-targeted
Figure 33. World CAR T-Cell-Based Drug Market Size Market Share by Type (2018-2029)
Figure 34. World CAR T-Cell-Based Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CAR T-Cell-Based Drug Market Size Market Share by Application in 2022
Figure 36. Lymphoma
Figure 37. Multiple Myeloma
Figure 38. CAR T-Cell-Based Drug Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
